This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Lucia Critelli: Innovator in Pharmaceutical Delivery Systems
Introduction
Lucia Critelli is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative delivery systems for pharmacologically active compounds. His work is characterized by a focus on enhancing the efficacy of drug delivery through novel chemical formulations.
Latest Patents
Lucia Critelli holds a patent for "Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds." This patent represents a breakthrough in the formulation of cationic lipids, which are essential for improving the intracellular delivery of various therapeutic agents. His innovative approach has the potential to significantly impact the effectiveness of drug therapies.
Career Highlights
Critelli is currently employed at Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., a prominent pharmaceutical company known for its commitment to research and development in the healthcare sector. His role at Sigma-Tau allows him to collaborate with other experts in the field and contribute to the advancement of pharmaceutical technologies.
Collaborations
Throughout his career, Lucia Critelli has worked alongside esteemed colleagues such as Nazareno Scafetta and Claudio Pisano. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the innovative potential of their projects.
Conclusion
Lucia Critelli's contributions to the field of pharmaceutical delivery systems exemplify the importance of innovation in healthcare. His patent and work at Sigma-Tau highlight his commitment to improving drug delivery methods, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
